From Rh Blood Group Antigen Antibody Testing to “Transfusionomics”
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Jing Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The Central Hospital of Shaoyang, Shaoyang, China. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Blood Grouping and Crossmatching, Isoantibodies. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Scientific Research Project of Hunan Provincial Health Commission, Shaoyang Science and Technology Plan Project.
Abstract (Originalsprache)
Objective
To analyze the results of Rh blood group antigen detection and irregular antibody identification of 5050 patients in China, and to explore the importance of Rh blood group typing before blood transfusion and to propose a new concept of “Transfusionomics”.
Methods
Use microcolumn gel detection card to type Rh blood group antigen of 5050 patients, and to screen and identify antibody. Use PCR amplification and Sanger sequencing techniques to detect RHD genotype.
Results
A total of 5030 D‐positive cases were detected in 5050 patients; the remaining 20 cases were detected as D‐negative. Totally, 49 cases of Rh blood group system antibodies were detected, which accounted for 70% of all detected antibodies. Of the 20 initial screening D‐negative patients, 11 cases had RHD gene deletion, and 9 cases had retained all of 10 exons.
Conclusion
Large‐scale testing and research on patients' Rh blood group antigen and antibody is aimed at avoiding red blood cell alloimmunization caused by blood transfusion, realizing individualized and precise blood transfusion. The large amount of data generated by blood transfusion laboratories every day will form an important basis for a new concept of “Transfusionomics”.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Blood Transfusion, The Central Hospital of Shaoyang, Shaoyang, China.
- Changchun Bioxun Biotechnology Limited Liability Company, Changchun, China.
- Department of Clinical Laboratory, Chengdu Angel Women's & Children's Hospital, Chengdu, China.
- Tianjin Dexiang Biotechnology Co., Ltd, Tianjin, China.
ORCID-Profile: Jing Zhong, Yan Zhang, Lingbo Li
Förderung
- Scientific Research Project of Hunan Provincial Health Commission
- Shaoyang Science and Technology Plan Project
Zitieren
APA
Zhong, J., Gao, Y., Mo, C., Zhang, Y., Luo, Y., & Li, L. (2026). From Rh Blood Group Antigen Antibody Testing to “Transfusionomics”. European Journal of Haematology. https://doi.org/10.1111/ejh.70042
Vancouver
Zhong J, Gao Y, Mo C, Zhang Y, Luo Y, Li L. From Rh Blood Group Antigen Antibody Testing to “Transfusionomics”. European Journal of Haematology. 2026. doi:10.1111/ejh.70042
BibTeX
@article{Zhong2026,
author = {Zhong, Jing and Gao, Yemei and Mo, Chunping and Zhang, Yan and Luo, Yan and Li, Lingbo},
title = {From Rh Blood Group Antigen Antibody Testing to “Transfusionomics”},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70042}
}
EUVIMED